Few would think to associate with rheumatoid arthritis skin cancer . But recent studies that may lead to the rescue of hundreds of thousands of lives, have shown that a drug to treat inflamed joints also has the ability to inhibit the growth of deadly skin tumors.
Scientists from the School of Biological Sciences at the University of East Anglia made this conclusion when viewed thousands of potential components in the search for new medicines. Tests have surprisingly shown that the new basic antirheumatic drug leflunomide significantly suppresses tumor growth in mice infected with human melanoma.
Moreover, the treatment effect increased when leflunomide combined with an experimental drug for the treatment of melanoma, called PLX4720. By joining together, the two agents immediately stopped the growth of tumors.
In this regard, encouraged by the fact that leflunomide has long passed the approval from the regulatory authorities, the drug is widely used, and medicine is aware of all of its side effects. So clinical studies on the use of leflunomide as a means of treating Skin Cancer You must pass much faster than it could happen in case of an unknown drug.
"The number of deaths from melanoma is growing, so that in medicine there is a strong need to create new, more effective treatments, - says one of the authors of the study, Dr. Grant Wheeler. - We are very optimistic about the results we have achieved. Leflunomide in combination with other drugs completely inhibits the growth of tumors. "
Industry News
Go back to the main page
Немає коментарів:
Дописати коментар